University of Louisville, USA
University of Louisville
Dr. Shirwan is Dr. Michael and Joan Hamilton Endowed Chair in Autoimmune Disease, Professor of Microbiology and Immunology, Director of Molecular Immunomodulation Program at the Institute for Cellular Therapeutics. He conducted his graduate studies at the University of California in Santa Barbara, CA, and postdoctoral studies at California Institute of Technology in Pasadena, CA. He joined the University of Louisville in 1998 after holding academic appointments at various institutions in the United States. Dr. Shirwan’s research focuses on the modulation of immune system for the treatment of immune-based diseases with particular focus on type 1 diabetes, transplantation, and vaccines. Dr. Shirwan is an inventor on 16 worldwide patens, widely published, lectured at numerous national/international conferences, served on study sections for various federal and non-profit funding agencies, and is on the Editorial Board of 16 scientific journals. He is member of several national and international societies and recipient of various awards.
Type 1 diabetes, Graft rejection, Bone marrow transplantation and Vaccines (cancer and infectious diseases)